Trends Remain Up

Today finally saw a meaningful pullback in the major indexes and most stocks; the realization that the Fed is likely to hike rates next month has created some jitters, and given that the S&P 500 and Nasdaq bumped up against their old highs last week (and that the advance has been narrow), further weakness wouldn’t be unusual.  

But until we see abnormal action, we’re going with the major trends, which continue to point up. Thus, we believe this dip, while probably having further to run, is buyable. That said, stock selection remains key, as we’re still seeing many stocks fall apart even as others remain in favor.  

This week’s list has a well-sponsored feel to it, which isn’t surprising given the market’s preference for bigger-cap stocks of late. Our Top Pick looks like a liquid leader following its recent run higher.

This is an excerpt from Cabot Top Ten Trader, which features the best trades to make every week.  Designed for experienced investors who want even more great growth stock ideas, this advisory recommends the best 10 stocks each month for short-term investment by aggressive growth investors.

Michael Cintolo is Cabot's Vice President of Investments and Chief Analyst of Cabot Growth Investor and Cabot Top Ten Trader. To read customer reviews of Cabot Top Ten Trader, click here. To read reviews of Cabot Growth Investor, click here.

Michael Cintolo can be found on Google Plus.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >

Diversify with Canadian Stocks

By Timothy Lutts on October 17, 2016

Canadian stocks are a good way to diversify your portfolio without taking on too much risk. And one Canadian stock in particular looks quite undervalued.Read More >